Investigators

Psychiatrists and neurologists running trials on compounds tracked in the CNS Pulse pipeline, ranked by recruiting and total trial activity.27 investigators linked to a tracked compound.

InvestigatorAffiliationRecruitingTrials
Carlos A Zarate, M.D.National Institute of Mental Health (NIMH)412
David Walling, Ph.D.Collaborative Neuroscience Research - Garden Grove22
Samuel McLean, MDUniversity of North Carollina at Chapel Hill22
Mark Pollack, M.D.Massachusetts General Hospital13
Aaron Koenig, MDSyndeio Biosciences12
Peter Ljubenkov, MDUniversity of California, San Francisco12
Rebecca B Price, PhDUniversity of Pittsburgh12
Maurizio Fava, MDMassachusetts General Hospital018
Debra Kelsh, MDVince and Associates Clinical Research06
Robert Findling, MDUniversity Hospitals Case Medical Center/Case Western Reserve University06
Marco Pappagallo, MDIcahn School of Medicine at Mount Sinai05
Craig Surman, MDMassachusetts General Hospital04
Elizabeth Berry-Kravis, MD, PhDRush University Medical Center04
Eric Sicard, MDAlgorithme Pharma Inc04
Philip Scheltens, MDAlheimer Research Center, VU medisch centrum04
Elizabeth Berry-Kravis, MDRush University Medical Center03
Olivier Rascol, MD, PhDToulouse University Hospital, France03
Sabrina Paganoni, MDMassachusetts General Hospital03
Vishaal Mehra, MDCalifornia Clinical Trials03
Christopher van Dyck, MDYale University02
Hakop Gevorkyan, MD, MBACalifornia Clinical Trials Medical Group02
Kevin Gray, MDAddiction Sciences Division - Medical University of South Carolina02
Larissa Mooney, MDDepartment of Psychiatry and Biobehavioral Sciences - UCLA02
Mark Leibowitz, MDCollaborative Neuroscience Network02
Matt Mandel, MDBioXcel Therapeutics02
Patrick VERMERSCH, MD, PhDUniversity of Lille, CHU of Lille, France02
TBD TBD02